MDPSX
Price
$97.53
Change
+$2.27 (+2.38%)
Updated
Nov 21 closing price
Net Assets
3.57M
VIMSX
Price
$77.09
Change
+$1.19 (+1.57%)
Updated
Nov 21 closing price
Net Assets
198.55B
Interact to see
Advertisement

MDPSX vs VIMSX

Header iconMDPSX vs VIMSX Comparison
Open Charts MDPSX vs VIMSXBanner chart's image
ProFunds Mid Cap Svc
Price$97.53
Change+$2.27 (+2.38%)
VolumeN/A
Net Assets3.57M
Vanguard Mid Cap Index Investor
Price$77.09
Change+$1.19 (+1.57%)
VolumeN/A
Net Assets198.55B
MDPSX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
MDPSX vs. VIMSX commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDPSX is a Hold and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. MDPSX (3.57M). VIMSX pays higher dividends than MDPSX: VIMSX (1.38) vs MDPSX (0.22). MDPSX was incepted earlier than VIMSX: MDPSX (24 years) vs VIMSX (28 years). MDPSX (2.89) is less costly to investors than VIMSX (0.17). MDPSX is a more actively managed with annual turnover of: 486.00 vs. VIMSX (16.00). VIMSX has a lower initial minimum investment than MDPSX: VIMSX (3000) vs MDPSX (15000). VIMSX annual gain was more profitable for investors over the last year : -0.27 vs. MDPSX (-6.57). VIMSX return over 5 years is better than : 43.59 vs. MDPSX (30.93).
MDPSXVIMSXMDPSX / VIMSX
Total Expense Ratio2.780.171,635%
Annual Report Gross Expense Ratio2.890.171,700%
Fund Existence24 years28 years-
Gain YTD-1.4385.404-27%
Front LoadN/AN/A-
Min. Initial Investment150003000500%
Min. Initial Investment IRAN/AN/A-
Net Assets3.57M199B0%
Annual Yield % from dividends0.221.3816%
Returns for 1 year-6.57-0.272,425%
Returns for 3 years17.3331.9054%
Returns for 5 years30.9343.5971%
Returns for 10 years50.40128.6639%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMLX14.681.11
+8.18%
Amylyx Pharmaceuticals
ACTG3.570.08
+2.29%
Acacia Research Corp
CTRE36.700.49
+1.35%
CareTrust REIT
CGCTU10.27N/A
N/A
Cartesian Growth Corp III
SMXT0.94-0.01
-0.78%
Solarmax Technology